Avenue Therapeutics, Inc. ATXI
0.50
0.14
38.89%
as of 24 Sep
- Market cap
- $680.0K
- P/E
- 0.0×
Follow ATXI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
37.93% | (157.75%) | (99.26%) | (163.30%) | |
| 23.62% | (103.84%) | (57.80%) | (90.50%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
32.57% | (158.79%) | (146.24%) | (488.05%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.55) | (0.59) | (0.33) | (0.42) | |
Free Cash Flow |
(1.74) | (1.83) | (1.08) | (1.38) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(28.99%) | (39.11%) | (30.01%) | (55.12%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(2.32) | 0.63 | 0.62 | 0.50 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.55) | (0.59) | (0.33) | (0.42) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates